Evidence map›Paper›PMID 41422270›Full record

ArticleCell death & disease2025

Targeting secreted PLA

Timothy J Mann, Ryung Rae Kim, Mila Sajinovic, Shadma Fatima, Vinod Kumar, Abdel Qader Al Bawab, Hiba Bahidh, Edwin Huang, Anya Salih, Enrico Gratton and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Human Group IIA Secreted Phospholipase AInternational journal of molecular sciences · 2026
    Review
  2. Review
  3. The innate immune mediator group IIA secreted phospholipase AFrontiers in cell and developmental biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Timothy J MannSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
Ryung Rae KimSchool of Pharmacy, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Mila SajinovicSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
Shadma FatimaSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
Vinod KumarSt Vincent's Hospital Clinical School, The University of New South Wales, Darlinghurst, NSW, Australia.ORCID http://orcid.org/0000-0002-7263-9917
Abdel Qader Al BawabSt Vincent's Hospital Clinical School, The University of New South Wales, Darlinghurst, NSW, Australia.
Hiba BahidhIngham Institute of Applied Medical Research, Liverpool, NSW, Australia.
Edwin HuangAustralian Institute of Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, Australia.
Anya SalihSchool of Life Science, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia.
Enrico GrattonLaboratory of Fluorescence Dynamics, University of California, Irvine, CA, USA.
Nathan MainIngham Institute of Applied Medical Research, Liverpool, NSW, Australia.
Maria George EliasSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
Isabelle Meyer-CarriveICP Firefly Pty Ltd., Alexandria, NSW, Australia.
Peter GalettisSt George Hospital Clinical School, The University of New South Wales, Kogarah, NSW, Australia.
Russell PickfordMark Wainwright Analytical Centre, The University of New South Wales, Kensington, NSW, Australia.
David G HarmanSchool of Science, Western Sydney University, Campbelltown, NSW, Australia.ORCID http://orcid.org/0000-0003-4376-832X
Jun ZengMedChemSoft Solutions. 42-44 Lakeview Dr, Scoresby, VIC, Australia.
Winston LiauwSt George Hospital Clinical School, The University of New South Wales, Kogarah, NSW, Australia.
Albert S MellickIngham Institute of Applied Medical Research, Liverpool, NSW, Australia.
Gregory James CooneyCharles Perkins Centre, University of Sydney, Camperdown, NSW, Australia.
Qihan DongCentral Clinical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Garry G GrahamSt Vincent's Hospital Clinical School, The University of New South Wales, Darlinghurst, NSW, Australia.
W Bret ChurchSchool of Pharmacy, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Pamela J RussellQueensland University of Technology, Brisbane, QLD, Australia.
Paul de SouzaNepean Clinical School, Faculty of Medicine and Health, University of Sydney, Kingswood, NSW, Australia.
Kieran F ScottSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia. kieran.scott@westernsydney.edu.au.ORCID http://orcid.org/0000-0002-6012-4107

Funding

Cancer Council NSW (Cancer Council New South Wales) Not availableCancer Council NSW (Cancer Council New South Wales) Not AvailableDepartment of Health | National Health and Medical Research Council (NHMRC) Not availableProstate Cancer Foundation of Australia (PCFA) Not availableProstate Cancer Foundation of Australia (PCFA) Not AvailableSt George and Sutherland Medical Research Foundation (St George & Sutherland Medical Research Foundation) Not applicableSt George and Sutherland Medical Research Foundation (St George & Sutherland Medical Research Foundation) Not Applicable
6 · The paper itself

Abstract

The secreted phospholipase A

Indexed as

ErbB ReceptorsGroup II Phospholipases A2Prostatic NeoplasmsVimentinAnimalsApoptosisCell Line, TumorCell ProliferationHumansMaleMicePeptides, CyclicProtein BindingEGFR protein, humanErbB ReceptorsGroup II Phospholipases A2Peptides, CyclicVimentin

Identifiers

PMID41422270
PMCPMC12876990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.